Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave, Sanger to Study SNPs on Chromosome 22

Premium

H

INXTON, UK--The Sanger Centre here said it will collaborate with Third Wave Technologies of Madison, Wis., to construct a high-density, single-nucleotide polymorphism map of human chromosome 22, which the center recently completed sequencing. Third Wave will develop and supply its proprietary Invader assays for approximately 2,000 unique SNPs positioned at roughly 40 Kb intervals along the chromosome. Sanger Centre said it will use the Invader chromosome 22 panel to type unamplified genomic DNA from a select group of several hundred individuals.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.